Skip to main content
DNA Labs India

TPM2 Gene Nemaline myopathy type 4 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

TPM2 Gene Nemaline myopathy type 4 NGS Genetic Test

Short Name: TPM2 NGS Genetic Test

Also known as: TPM2 Gene Mutation Analysis, Nemaline Myopathy Type 4 Genetic Test, TPM2 Gene Sequencing, TPM2-Related Myopathy NGS Test

TPM2 Gene Nemaline myopathy type 4 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are usually released within 3 to 4 weeks after the sample reaches the laboratory and passes quality control.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this NGS genetic test is to detect clinically significant variants in the TPM2 gene and provide molecular confirmation of Nemaline Myopathy Type 4.

Test Code
4395
CPT Code
Not Applicable
ICD Code
G71.2
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are usually released within 3 to 4 weeks after the sample reaches the laboratory and passes quality control.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

A pre-test genetic counselling session is recommended to document clinical history, draw a pedigree chart, and obtain informed consent. No fasting is required.

Method: Venipuncture / Dried blood spot / DNA submission

Step 2

Laboratory Analysis

A small blood sample is collected by venipuncture, or a dried blood spot is placed on the FTA card as applicable. The sample is labelled and prepared for transport.

Step 3

Report Delivery

The sample is transported to the laboratory under appropriate conditions. After NGS sequencing and clinical review, the report and raw data files are shared with the patient.

Timeline: Reports are usually released within 3 to 4 weeks after the sample reaches the laboratory and passes quality control.

Patient Instructions

1
Before the Test:A pre-test genetic counselling session should be completed to review personal and family history, draw an inheritance pedigree, and ensure informed consent. No fasting is required.
2
During the Test:The sample is collected as whole blood in an EDTA tube, extracted DNA, or one drop of blood on an FTA card. The sample is then sent to the laboratory under recommended storage conditions.
3
After the Test:The clinical geneticist reviews the sequencing data, classifies any variants, and prepares the final report. Patients receive the clinical report along with raw FASTQ and VCF files where applicable.

About This Test

Who Should Get This Test

The purpose of this NGS genetic test is to detect clinically significant variants in the TPM2 gene and provide molecular confirmation of Nemaline Myopathy Type 4.

How to Prepare

  • Complete genetic counselling before sample collection
  • No fasting needed
  • Bring previous neurology reports and family history documents
  • For FTA card, ensure blood spot is dry before sealing in the bag
  • Label sample with patient name, date of birth and collection date

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"A confirmed pathogenic variant in TPM2 is clinically significant and should be followed by structured genetic counselling to discuss inheritance, family testing, and reproductive options."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeAs required: 3-5 ml EDTA blood / 5-10 µg extracted DNA / one FTA card blood spot
ContainerEDTA Vacutainer / Sterile DNA vial / FTA card
Collection MethodVenipuncture / Dried blood spot / DNA submission

Sample Stability

Whole blood in EDTA
Extracted DNA
FTA card blood spot
Sample Rejection Criteria:
  • Haemolysed or clotted whole blood sample
  • Insufficient DNA quantity or concentration
  • Sample with incorrect or missing labelling
  • Wet, contaminated, or severely degraded FTA card specimen
  • Sample not accompanied by required clinical details or consent

Understanding Your Results

Results should be interpreted by a clinical geneticist in the context of clinical presentation, family history, and examination findings.
📊

Negative

No pathogenic or likely pathogenic variant was detected in the TPM2 gene. Clinical correlation is advised, and other genetic causes may be considered if symptoms persist.

📊

Positive

A pathogenic or likely pathogenic variant was identified in TPM2. This confirms a molecular diagnosis of TPM2-related Nemaline Myopathy Type 4 in the appropriate clinical context.

📊

Variant of Uncertain Significance (VUS)

A genetic variant was found, but its clinical significance is not yet clear. Additional family testing or further evaluation may be needed to clarify the result.

⚠️ When to Consult a Doctor:

If the patient has symptoms of muscle weakness, respiratory difficulty, or developmental delay, or if the test result is positive or uncertain, consult a neurologist or clinical geneticist for management and counselling.

Limitations

  • This test analyzes the TPM2 gene only and does not evaluate other genes associated with nemaline myopathy
  • Standard NGS may not reliably detect large structural rearrangements unless dedicated bioinformatics analysis is performed
  • Variants of uncertain significance may require additional family studies or functional evaluation
  • A negative result does not completely exclude the possibility of a genetic cause not detectable by current sequencing methods

Risks & Considerations

  • Minimal pain or bruising at the venipuncture site
  • Very small risk of infection at the blood collection site
  • No physical risk from the genetic testing itself

Interfering Factors

  • Contaminated or degraded DNA sample
  • Sample transported outside recommended temperature range
  • Insufficient quantity of extracted DNA
  • FTA card stored in humid or wet condition
  • Recent allogeneic bone marrow transplant can affect genetic testing results

Compare With Similar Tests

TestTPM2 Gene Nemaline myopathy type 4 NGS Genetic TestTPM2 Gene NGS Genetic TestSanger Sequencing for Familial VariantWhole Exome Sequencing
ComparisonTPM2 Gene Nemaline myopathy type 4 NGS Genetic Test

Frequently Asked Questions

What is Nemaline Myopathy Type 4?
Nemaline Myopathy Type 4 is a rare genetic muscle disorder caused by mutations in the TPM2 gene. It can present with muscle weakness, respiratory difficulties, scoliosis, delayed motor development, and difficulty swallowing. Genetic testing helps confirm the diagnosis.
How does the TPM2 gene cause Nemaline Myopathy?
TPM2 provides instructions for a protein important for normal muscle contraction. Pathogenic changes in this gene can disrupt muscle function and lead to features of Nemaline Myopathy Type 4.
What is an NGS genetic test?
Next-Generation Sequencing is a high-throughput DNA sequencing technology that can analyze multiple gene regions accurately. This test specifically analyzes the TPM2 gene for clinically significant variants.
What are the symptoms of Nemaline Myopathy Type 4?
Common symptoms include muscle weakness, respiratory difficulties, scoliosis, delayed motor development, difficulty swallowing, and poor feeding. Symptoms may vary in severity from mild to severe.
How is Nemaline Myopathy Type 4 diagnosed?
The diagnosis is based on clinical evaluation and confirmed by genetic testing. Detection of a pathogenic variant in the TPM2 gene confirms the diagnosis in an appropriate clinical context.
What is the cost of the TPM2 gene NGS genetic test?
The cost is Rs 20000 including sample collection, NGS analysis, clinical interpretation, and raw data files. Free home sample collection is also available for online bookings.
What type of sample is accepted for this test?
The test accepts whole blood in an EDTA tube, extracted DNA, or one drop of blood on an FTA card.
Is fasting required before sample collection?
No, fasting is not required for this genetic test.
When will I get the report?
The report is typically available in 3 to 4 weeks after the sample reaches the laboratory and passes quality control.
Will I receive raw data files with the report?
Yes, DNA Labs India provides raw data, FASTQ, and VCF files along with the conclusive clinical test report for transparency.
Why is genetic counselling important before testing?
Genetic counselling helps document the family history, draw a pedigree chart, explain risks and benefits, and guide informed decision-making. It also prepares the patient and family for result interpretation.
Can this test help with reproductive planning?
Yes, confirming a genetic cause helps parents understand recurrence risk and explore options such as prenatal testing or preimplantation genetic testing with the help of a clinical geneticist.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.